Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $32.87 which represents a slight increase of $0.22 or 0.67% from the prior close of $32.65. The stock opened at $32.87 and ...

Palantir Technologies (NASDAQ:PLTR) has been described as the best pure-play stock in artificial intelligence. The market ...

Viking Therapeutics Inc’s profitability metrics reveal financial health. The company currently boasts a gross margin of -34.83%. The profit margin, also known as the revenue ratio or gross profit ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Viking Therapeutics investors face challenges as stock plummets, cash runway helps but betting on early stage biopharma ...

VKTX Stock Valuation & Estimates The company is trading at a premium to the industry. Going by the price/book ratio, the stock currently trades at 4.92, trailing 12-month book value, higher than 3 ...

The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly ...

Jefferies analyst Roger Song maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) yesterday and set a price target of ...

Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price ... Viking Therapeutics, Inc. (VKTX). Viking Therapeutics currently ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) is a clinical-stage biopharmaceutical company focused on the development of novel ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.